$469 Million is the total value of SECTOR GAMMA AS's 31 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TAK | Exit | TAKEDA PHARMACEUTICAL CO LTDsponsored ads | $0 | – | -30,873 | -100.0% | -0.10% | – |
| SGMO | Exit | SANGAMO THERAPEUTICS INC | $0 | – | -211,698 | -100.0% | -0.28% | – |
| LLY | Exit | LILLY ELI & CO | $0 | – | -15,524 | -100.0% | -0.33% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -63,913 | -100.0% | -0.49% | – |
| PTLA | Exit | PORTOLA PHARMACEUTICALS INC | $0 | – | -130,625 | -100.0% | -0.50% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -170,896 | -100.0% | -1.04% | – |
| UHS | Exit | UNIVERSAL HLTH SVCS INCcl b | $0 | – | -65,864 | -100.0% | -1.51% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -28,458 | -100.0% | -1.71% | – |
| QGEN | Exit | QIAGEN NV | $0 | – | -434,111 | -100.0% | -2.35% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.